Sunovion Pharmaceuticals Enterprise Account Executive Salaries in Boston
The average Sunovion Pharmaceuticals Enterprise Account Executive in Boston earns an estimated $115,302 annually, which includes an estimated base salary of $75,082 with a $40,220 bonus. Sunovion Pharmaceuticals' Enterprise Account Executive compensation is $1,828 more than the US average for a Enterprise Account Executive. Enterprise Account Executive salaries at Sunovion Pharmaceuticals in Boston can range from $43,867 - $152,000.
In Boston, The Business Development Department at Sunovion Pharmaceuticals earns $5,313 more on average than the Finance Department.
Last updated 3 years ago.
- $75,082
- avg. base
- $40,220
- avg. bonus
Enterprise Account Executive Salaries at Sunovion Pharmaceuticals
In Boston, Enterprise Account Executives earn $7,075 more than Account Managers, and $18,621 less than Business Development Managers.
Compensation at Sunovion Pharmaceuticals by Department
In Boston, The Business Development Department averages $5,313 more than the Finance Department, and $17,483 less than the HR Department
Enterprise Account Executive Compensation by Gender (All Companies)
The average female Enterprise Account Executive at companies similar size to Sunovion Pharmaceuticals reported making $102,479, while the average male Enterprise Account Executive at similar sized companies reported making $94,544.
Enterprise Account Executive Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Enterprise Account Executive at companies similar size to Sunovion Pharmaceuticals reported making $111,125, while the average Native American Enterprise Account Executive at similar sized companies reported making $50,000.
How Enterprise Account Executives at Sunovion Pharmaceuticals Rate Their Compensation
The majority of Enterprise Account Executives at Sunovion Pharmaceuticals believe they're not compensated fairly. 67% of Enterprise Account Executives at Sunovion Pharmaceuticals say they receive annual bonuses, and the vast majority (80%) are satisfied with their benefits. See more compensation ratings at Sunovion Pharmaceuticals
